Oxygenta Pharma Closes Trading Window Until Post-Sept 2026 Results

Oxygenta Pharmaceutical Ltd has announced the closure of its trading window for all designated persons, their immediate relatives, and connected persons. This closure is effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the financial results for the quarter and half-year ending September 30, 2026. The company will convene a board meeting to approve these financial results. This measure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct to prevent insider trading.